Bleeding after Cardiopulmonary Bypass

New England Journal of Medicine

Volumn 314, Issue 22, 1986, Pages 1446-1448

  Harker, Laurence A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; CARDIOPULMONARY BYPASS; EDITORIAL; HUMAN; POSTOPERATIVE COMPLICATION;

CARDIOPULMONARY BYPASS; HEMORRHAGE; HUMANS; POSTOPERATIVE COMPLICATIONS;

EID: 0023058864     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198605293142209     Document Type: Editorial

References (13)

1. Bachmann F, McKenna R, Cole ER, Najafi H. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 70: 76–85.
2. McKenna R, Bachmann F, Whittaker B, Gilson JR, Weinberg M Jr. The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 70: 298–308.
3. Harker LA, Malpass TW, Branson HE, Hessel EA II, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release. Blood 1980; 56: 824–34.
4. Beurling-Harbury C, Galvan CA. Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post–cardiopulmonary bypass patients and in patients with severe valvular heart disease. Blood 1978; 52: 13–23.
5. Mezzano D, Aranda E, Urzua J, et al. Changes in platelet beta-thrombo-globulin, fibrinogen, albumin, 5-hydroxytryptamine, ATP, and ADP during and after surgery with extracorporeal circulation in man. Am J Hematol (in press).
6. Musial J, Niewiarowski S, Hershock D, Morinelli TA, Colman RW, Edmunds LH Jr. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med 1985; 105: 514–22.
7. Mammen EF, Koets MH, Washington BC, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985; 11: 281–92.
8. Malpass TW, Hanson SR, Savage B, Hessel EA II, Harker LA. Prevention of acquired transient defect in platelet plug formation by infused prostacyclin. Blood 1981; 57: 736–40.
9. Malpass TW, Amory DW, Harker LA, Ivey TD, Williams DB. The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1984; 87: 550–5.
10. Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 308: 8–12.
11. Kobrinsky NL, Israels E, Gerrard JM, et al. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet 1984; 1: 1145–8.
12. Salzman EW, Weinstein MJ, Weintraub RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: a double-blind randomized trial. N Engl J Med 1986; 314: 1402–6.
13. Czer L, Bateman T, Gray R, et al. Prospective trial of DDAVP in treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass. Circulation 1985; 72: Suppl 3: III–130.